Skip to main content
medichelpline
Join Free
Back to Drug Index
General MedicationsINJECTIONGeneric

CERADON

CEFOTIAM HYDROCHLORIDE

Standard Dose
EQ 1GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued

Key Takeaways

  • Primary indication: Review priority: STANDARD Marketing status: Discontinued
  • Approval overview CERADON is listed in Drugs@FDA under application 050601 (NDA).
  • Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFOTIAM HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 1GM BASE/VIAL Sponsor TAKEDA Submission history Latest submission status date: 1988-12-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview CERADON is listed in Drugs@FDA under application 050601 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFOTIAM HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 1GM BASE/VIAL Sponsor TAKEDA Submission history Latest submission status date: 1988-12-30 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.